The ADAURA Update: What Eight-Year Overall Survival Data Mean for Adjuvant Practice

In this segment, the panel discusses the eight-year overall survival update from the adjuvant TKI trial being presented at the presidential session of this year's World Conference on Lung Cancer. You will hear what long-term follow-up adds to an already practice-defining dataset, including what recurrence patterns look like over time, what CNS outcomes tell us about the durability of intracranial protection, and whether the survival curves continue to separate or show signs of catching up. The panel also addresses the practical questions that remain unanswered, including how to counsel patients with smaller tumors who fall at the edge of the studied population and what the right duration of adjuvant therapy is given the varying time periods used across trials in this space.